Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.720
+0.260 (5.83%)
At close: Jul 6, 2026, 4:00 PM EDT
4.800
+0.080 (1.69%)
After-hours: Jul 6, 2026, 7:58 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $336 million as of July 6, 2026. Its market cap has increased by 238.39% in one year.
Market Cap
336.00M
Enterprise Value
162.89M
1-Year Change
238.39%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $336.00M, a decrease of -42.80%. That is a compound annual growth rate of -8.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 336.00M | 284.38% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 336.55M |
| Immuneering | 335.78M |
| InflaRx | 329.94M |
| Lyell Immunopharma | 327.84M |
| Greenwich LifeSciences | 322.92M |
| Foghorn Therapeutics | 311.18M |
| Cartesian Therapeutics | 311.15M |
| Neumora Therapeutics | 309.42M |